South Korea possesses one of the most advanced healthcare systems globally, characterized by a high density of clinics and a tech-savvy population. In the wake of global pandemics, there is an intensified demand for a high-performance covid quick test to maintain public health stability in densely populated urban centers like Seoul and Busan.
The market is currently shifting toward decentralized testing. Patients prefer rapid results at the point of care, driving the adoption of the pregnancy test card and various viral kits in pharmacies and private clinics, reducing the burden on major university hospitals.
Furthermore, the regional focus on seasonal respiratory health and the increasing mobility of the population have made the influenza rapid test kit a staple in annual health screenings, requiring manufacturers to adhere to strict MFDS (Ministry of Food and Drug Safety) regulations.